Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

257P - Parity and molecular breast tumour sub types: A study conducted in Libya

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Breast Cancer

Presenters

Ans Malek

Citation

Annals of Oncology (2020) 31 (suppl_4): S340-S347. 10.1016/annonc/annonc260

Authors

A.B. Malek1, E. Gusbi1, H. Ahmed2

Author affiliations

  • 1 General Medicine/radiology, Mitiga Military Hospital, 125 Ad - Tripoli/LY
  • 2 Research, Tripoli University, 125 Ad - Tripoli/LY

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 257P

Background

Relationships of parity with breast cancer risk are complex. Breast cancer expresses many molecular subtypes with different prognoses and etiology. Parity is associated with decreased risk of postmenopausal hormone receptor-positive breast tumours, however, it may increase the risk for basal-like subtype of breast cancers and early-onset tumours. Previous studies have shown that reproductive factors are differentially associated with breast cancer (BC) risk by subtypes. The aim of this study was to investigate associations between reproductive factors and BC subtypes, and whether these vary by age at diagnosis.

Methods

We have conducted a study of pregnant women with breast cancer attending the breast clinics in Tripoli, Libya from 2002 to 2017. The reproductive and surgical information was obtained from the records. Statistical analysis was done using SPSS 22.

Results

524 pregnant women was diagnosed with breast tumour in the period of 15 years. The mean age at onset was 34.9 +/-4 SD and ranged from 25 to 40 years, while the onset of menarche ranged from 10 to 16 years with mean of 11.3+/-1.48. Family history of breast cancer in 165 cases (31.5%). Only 3 cases presented with bilateral breast mass, while 266 (50.8%) had left breast mass and 254 (48.5%) in the right. Histopathology showed that 31 biopsies was grade I, 253 grade II and 209 grade III. Also, estrogen receptor was positive in 251 (47.9%) cases, progesterone positive in 228 (43.5%) and HERT-neu in 164 (31.3%). Regarding the molecular subtype, Basal-like was the most common one in 194 cases (37%), then Luminal A in 165 (31.5), Luminal B in 88 (16.8%), HER2-en positive in 74 (14.1%) respectively.

Conclusions

The cases presented with breast cancer during pregnancy have high rates of basal-like subtypes compared to previous reports. Further researches are needed to ascertain the relation between pregnancy and molecular subtype of breast cancer.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Tripoli University Hospital.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest..

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.